跳至主要内容
临床试验/DRKS00014663
DRKS00014663已完成不适用

A treatment algorithm reduces perioperative blood loss in children with congenital stenotic heart disease - TAPAC

Herz- und Diabeteszentrum Nordrhein-Westfalen Universitätsklinik der Ruhr-Universität Bochum Institut für Laboratoriums- und Transfusionsmedizin0 个研究点目标入组 627 人开始时间: 2020年1月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
627

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Patients with stenotic congenital heart defects (CHD) undergoing cardiac surgery with cardiopulmonary bypass at the Center for Congenital Heart Defects of the Heart and Diabetes Center NRW in the period from August 2008 to May 2017.
  • The following CHD were included: valve and vascular stenosis of the aorta and pul-monary artery, coarctation of the aorta, Tetralogy of Fallot, hypertrophic obstructive cardiomyopathy, atrial septal defect, ventricular septal defect and atrioventricular sep-tal defect.

排除标准

  • Preoperative antiplatelet therapy (<10 days before surgery), thrombocytopenia (<100*103 *µl-1), coagulation disorder, drugs inducing AVWS, untreated hypothyroidism and administration of von Willebrand factor concentrates or desmopressin (only in the historical cohort)

研究者

发起方
Herz- und Diabeteszentrum Nordrhein-Westfalen Universitätsklinik der Ruhr-Universität Bochum Institut für Laboratoriums- und Transfusionsmedizin

相似试验